CRAWFORD VICTOR L.
Insider transactions at 3 companies
This page shows all SEC Form 4 filings attributed to CRAWFORD VICTOR L.. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HSY | Award / Grant | 99 | — | — | Apr 1, 2025 | |
| HSY | Award / Grant | 114 | — | — | Mar 15, 2025 | |
| HSY | Award / Grant | 252 | — | — | Jan 1, 2025 | |
| HSY | Award / Grant | 221 | — | — | Oct 1, 2024 | |
| HSY | Award / Grant | 232 | — | — | Jul 1, 2024 | |
| HSY | Award / Grant | 220 | — | — | Apr 1, 2024 | |
| HSY | Award / Grant | 271 | — | — | Jan 1, 2024 | |
| HSY | Award / Grant | 230 | — | — | Jan 1, 2024 | |
| HSY | Award / Grant | 211 | — | — | Oct 1, 2023 | |
| HSY | Award / Grant | 170 | — | — | Jul 1, 2023 | |
| HSY | Award / Grant | 168 | — | — | Apr 1, 2023 | |
| HSY | Award / Grant | 183 | — | — | Jan 1, 2023 | |
| HSY | Award / Grant | 179 | — | — | Oct 1, 2022 | |
| CAH | CEO, Pharmaceutical Segment | Tax Withholding | 29,952 | $69.32 | $2,076,273 | Aug 15, 2022 |
| CAH | CEO, Pharmaceutical Segment | Award / Grant | 36,536 | — | — | Aug 9, 2022 |
| HSY | Award / Grant | 184 | — | — | Jul 1, 2022 | |
| HSY | Award / Grant | 185 | — | — | Apr 1, 2022 | |
| HSY | Award / Grant | 208 | — | — | Jan 1, 2022 | |
| CAH | CEO, Pharmaceutical Segment | Tax Withholding | 4,391 | $51.44 | $225,873 | Nov 15, 2021 |
| HSY | Award / Grant | 235 | — | — | Oct 1, 2021 | |
| CAH | CEO, Pharmaceutical Segment | Tax Withholding | 19,991 | $51.70 | $1,033,535 | Aug 15, 2021 |
| CAH | CEO, Pharmaceutical Segment | Award / Grant | 23,946 | — | — | Aug 3, 2021 |
| HSY | Award / Grant | 230 | — | — | Jul 1, 2021 | |
| HSY | Award / Grant | 251 | — | — | Apr 1, 2021 | |
| HSY | Award / Grant | 264 | — | — | Jan 1, 2021 | |
| CAH | CEO, Pharmaceutical Segment | Tax Withholding | 4,362 | $57.43 | $250,510 | Nov 15, 2020 |
| HSY | Award / Grant | 282 | — | — | Oct 1, 2020 | |
| CAH | CEO, Pharmaceutical Segment | Tax Withholding | 3,080 | $53.68 | $165,334 | Aug 15, 2020 |
| HSY | Award / Grant | 478 | — | — | Jul 1, 2020 | |
| PLAY | Award / Grant | 4,504 | — | — | Apr 27, 2020 | |
| CAH | CEO, Pharmaceutical Segment | Tax Withholding | 4,144 | $54.75 | $226,884 | Nov 15, 2019 |
| CAH | CEO, Pharmaceutical Segment | Award / Grant | 26,190 | — | — | Aug 15, 2019 |
| PLAY | Award / Grant | 2,418 | — | — | Apr 11, 2019 | |
| CAH | CEO, Pharmaceutical Segment | Award / Grant | 26,028 | — | — | Nov 15, 2018 |
| PLAY | Award / Grant | 3,001 | — | — | Apr 12, 2018 | |
| PLAY | Award / Grant | 2,094 | — | — | Apr 7, 2017 | |
| PLAY | Award / Grant | 1,392 | — | — | Aug 9, 2016 | |
| 0001076405 | SVP, Glbl Ops&Sys Transformatn | Disposition | 79,669 | — | — | Feb 26, 2010 |
| 0001076405 | SVP, Glbl Ops&Sys Transformatn | Award / Grant | 25,177 | — | — | Feb 3, 2010 |
| 0001076405 | SVP, Glbl Ops&Sys Transformatn | Sale | 14,800 | $22.02 | $325,896 | Mar 31, 2009 |
| 0001076405 | SVP, Glbl Ops&Sys Transformatn | Sale | 3,831 | $16.95 | $64,935 | Mar 4, 2009 |
| 0001076405 | SVP, Glbl Ops&Sys Transformatn | Award / Grant | 26,710 | — | — | Mar 1, 2009 |
| 0001076405 | SVP, Glbl Ops&Sys Transformatn | Sale | 14,800 | $20.07 | $297,036 | Jan 30, 2009 |
| 0001076405 | SVP, Glbl Ops&Sys Transformatn | Tax Withholding | 36,944 | $21.55 | $796,143 | Dec 19, 2008 |